Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression.
about
Neurosteroids in the context of stress: implications for depressive disordersElevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depressionSex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor.Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal functionDecreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjectsHippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposureChronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the ratPersistent anxiolytic affects after chronic administration of the CRF₁ receptor antagonist R121919 in rats.Risk and resilience: genetic and environmental influences on development of the stress response.Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleepRole of corticotropin releasing factor in anxiety disorders: a translational research perspectiveCorticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances.Sexually Dimorphic Changes of Hypocretin (Orexin) in DepressionDendritic cell nuclear protein-1, a novel depression-related protein, upregulates corticotropin-releasing hormone expression.Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein.Neonatal rearing conditions distinctly shape locus coeruleus neuronal activity, dendritic arborization, and sensitivity to corticotrophin-releasing factor.Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-betaReduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's diseaseCommon genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart StudyExpression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus.Neurobiology of the stress response early in life: evolution of a concept and the role of corticotropin releasing hormoneDepression-like behavior and stressor-induced neuroendocrine activation in female prairie voles exposed to chronic social isolationThe molecular bases of the suicidal brain.Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.Cell pathology in bipolar disorder.Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus.GABA regulates corticotropin releasing hormone levels in the paraventricular nucleus of the hypothalamus in newborn mice.Neuropeptides involved in the pathophysiology of schizophrenia and major depression.The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular HealthChanges in the immune system in depression and dementia: causal or coincidental effects?Cellular abnormalities in depression: evidence from postmortem brain tissueCorticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology.Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.Importance of studying the contributions of early adverse experience to neurobiological findings in depression.Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress.Brain-immune interactions and disease susceptibility.Effects of psychologic stress on fetal development and pregnancy outcome.
P2860
Q24646222-80F65526-349B-4D8C-A732-67A399119040Q24654669-AEC2A6BC-C8A0-4B88-B1D6-94E8F1749171Q26866575-57E86F52-C1FB-41F2-8F68-82AA9141B201Q28144958-CCB4FCB9-CC0F-40CB-80CA-A584CB6F2C8EQ28297733-0E242527-333A-4743-9157-53154C8DB790Q28346146-D16B59E9-502E-4278-8800-5CC89005C279Q28742318-ADCB2955-1B39-4066-A22A-6DBE55476B8AQ30467178-8A4081CF-96FC-49E5-A978-9774EECBEA60Q30482099-0DDEE319-A853-4CE5-989F-C03B73EA147CQ30493526-8541A983-ADE4-4C57-AABA-1731A924127EQ30498732-A8AECFFE-02B5-402A-B7A0-1B2C1E41BDC1Q30502566-844C0895-7BC6-4CC0-B88D-AB5B198EC1BFQ30578605-AA652E70-40C7-42C7-B69B-0277C78D074DQ33329785-EA63A6ED-4020-45E0-AEBC-99B8FA68F16BQ33603710-D2ECB27F-5703-481B-9C39-B1D600DF34ADQ33652384-1503E3BC-F432-4B5E-9B24-EBEEA4CA25BAQ33713194-6ED23626-C187-44F0-9143-7C8BCB5D4F91Q33802083-71DFF7A5-8E0C-4B81-8C6B-D2F80D8118D8Q33935828-368BF1B9-E876-4B84-AA3D-CDE0FC7415CDQ33944174-C52BF37E-5D23-4C15-B33E-93153D0E8779Q33998929-80D37523-30C9-432A-9844-A2E67C51DAF2Q34248978-F66F0114-AC6F-4A0F-96F7-81CFE56EE908Q34416955-096A3B45-AEA7-4577-9300-9B41E835D719Q34425186-D654BCEB-8A2C-43E9-93EC-C1B2FCFAB222Q34445375-164CDAED-BFEA-4FCA-A958-E0045C41FECFQ34514099-48DC236E-9634-4CF0-AF50-E6560E9F7537Q34580335-8680B386-6382-438B-B4D7-DDE5E8014534Q34692741-9ABAE456-363F-4FC5-A31F-FD113295BF16Q34907730-F9D05F0E-956E-4316-9084-015E31DD68FEQ35024351-F9E1A354-29FA-4784-83DE-99169BF77D33Q35130197-E1699156-4AF7-4A47-8506-CD71CB861433Q35227472-F83E631B-5DB0-4B6B-B8F8-E9608DD0EA51Q35236725-59F903FB-4CD5-43F5-A1FD-4810CE150D29Q35236779-E958CF79-A1B5-409E-81D5-FDBADEB6D696Q35682223-7058EC36-59D9-4D5F-8023-5ECCD684F86EQ35694088-5EEA4B2A-62CE-4B00-A870-9FC2941115A7Q35701124-C18BECF0-CF62-4065-9A2C-A94E3A4C862BQ35952219-A884B8AC-DCC1-4A15-8964-CC206E41CA99Q36026815-290C424E-9205-4E55-9D79-19D20753038FQ36228218-8928BB74-CBCB-48C1-85AB-ACFA386E0F71
P2860
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression.
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Corticotropin-releasing hormon ...... imer's disease and depression.
@ast
Corticotropin-releasing hormon ...... imer's disease and depression.
@en
Corticotropin-releasing hormon ...... imer's disease and depression.
@nl
type
label
Corticotropin-releasing hormon ...... imer's disease and depression.
@ast
Corticotropin-releasing hormon ...... imer's disease and depression.
@en
Corticotropin-releasing hormon ...... imer's disease and depression.
@nl
prefLabel
Corticotropin-releasing hormon ...... imer's disease and depression.
@ast
Corticotropin-releasing hormon ...... imer's disease and depression.
@en
Corticotropin-releasing hormon ...... imer's disease and depression.
@nl
P2093
P356
P1476
Corticotropin-releasing hormon ...... imer's disease and depression.
@en
P2093
Hoogendijk WJ
Lucassen PJ
Raadsheer FC
Tilders FJ
van Heerikhuize JJ
P304
P356
10.1176/AJP.152.9.1372
P407
P577
1995-09-01T00:00:00Z